antiretroviral%20therapy%20for%20hiv-infected%20adults
ANTIRETROVIRAL THERAPY FOR HIV-INFECTED ADULTS
Antiretroviral therapy is recommended for all HIV-infected individuals regardless of CD4 count to decrease morbidity and mortality associated with HIV infection.
Goals of antiretroviral treatment are suppression of viral load for maximum possible duration, restore & preserve immunologic function, reduce HIV-related morbidity & mortality and prevent HIV transmission.
Urgent initiation of antiretroviral treatment is recommended in the following individuals: pregnant women, patients w/ HIV with coinfections (HBV, HCV, active tuberculosis), AIDS-defining illness, HIV-associated nephropathy, low CD4 counts, acute opportunistic infections and HIV HBV with evidence of chronic liver disease.

Antiretroviral Therapy for HIV-Infected Adults Drug Information

Drug Information

Indication: HIV-1 infection in combination w/ other antiretroviral agents in treatment-naive adults.

Indication: HIV-1 infection in antiretroviral treatment-experienced adult patients in combination w/ a boosted PI & ot...

Indication: HIV infection in antiretroviral treatment-experienced adult patients (in combination w/ ritonavir & other ...

Indication: In combination w/ other antiretroviral agents for HIV-1 infections in adult & paed patients ≥12 yr. Chr...

Indication: HIV infected adults & adolescents >12 yr in combination w/ other antiretroviral drugs.

Indication: In combination w/ other antiretroviral for treatment of HIV infected adult & childn.

Indication: HIV infection. 

Indication: HIV infection.

Indication: HIV infection.

Indication: Reduction of maternal-foetal transmission rate of HIV. Syr: In combination w/ other antiretroviral agents for ...

1  /  4
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 16 Oct 2020
More than half of the patients who recovered from COVID-19 experienced persistent fatigue regardless of their disease severity, shows a study presented at ECCVID 2020.